A link post sharing @DigitalMehmet's take on tirzepatide and semaglutide beyond diabetes, with hopes for joint and brain conditions. Light on detail.
Recap by typeshit. Post by Aiden MC on X.
Avi Roy points out that the largest test so far found no memory benefit from the drug in Ozempic, despite hopes raised by health record studies.
Balwinder Singh and Raman Baweja link GLP-1 use to less kidney replacement therapy in bipolar patients with CKD, and flag lithium toxicity cases.
Yale Medicine says 5% to 10% of people on GLP-1 weight loss drugs see little result, and points to diet as one factor that can blunt the effect.
24:26
A doctor's explainer sorting peptides into eight broad categories. An evergreen overview for anyone still learning the basics.
In a USA Today op-ed, she cites her small 25-person vegan diet study where HbA1c fell from 7.6% to 6.6%, and calls on Medicare to pay for nutrition programs.
A short post from Hany Ragy on trypanophobia and the pill form of Wegovy, linking out for more on why needle-averse patients may lean toward oral semaglutide.
Loading…